January 10, 2008 - Piedmont Hospital has been recognized as Best in Atlanta for Overall Cardiac Care and Cardiac Surgery for 2008, according to The Tenth Annual HealthGrades Hospital Quality in America Study.

January 10, 2008 - Patients who received OrbusNeich’s Genous Bio-engineered R Stent had significantly fewer major cardiac adverse events (MACE) than patients who received FDA-cleared drug-eluting stents in a study conducted at Federico II University of Naples in Naples, Italy.

January 10, 2008 - ThromboVision Inc., a biomedical diagnostics company, has initiated clinical trials of its ThromboGuide (T-Guide) Platelet Function Monitor. Enrollment and data collection are under way at four key research institutes as it prepares to apply for 510(k) FDA clearance.

The T-Guide consists of a disposable test kit and a point-of-care base unit. The system is designed to help physicians individualize antiplatelet therapy that they use to prevent heart attacks, strokes and stent occlusions.

January 9, 2008 - The Certification Commission for Healthcare Information Technology with its software design partner, the MITRE Corp., stated that their work to build a testing tool to evaluate compliance of electronic health records (EHR) with criteria for interoperability, named project LAIKA, will be further advanced by the Commission’s collaboration with two organizations that play major roles in healthcare IT connectivity.

January 9, 2008 - Frost & Sullivan has recognized Philips Medical Systems with the 2007 North American Medical Imaging Company of the Year Award for its success across the entire medical imaging industry and double-digit growth.

Philips Medical Systems is a well regarded company, prized for its strength of leadership in healthcare technology and its innovative approach to product development, reflected in Philips’ “Sense and Simplicity” brand promise.

January 9, 2008 - Avista Capital Partners, a leading private equity firm, has completed its acquisition of Bristol-Myers Squibb Medical Imaging, a business unit of Bristol-Myers Squibb that supplies medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures.

January 8, 2008 – The cardiac imaging community has until Jan. 12 to contribute to the Centers for Medicare and Medicaid Services (CMS) public comments forum regarding CMS’ proposed National Coverage Decision (NCD) that would limit reimbursement for coronary CTA to just two clinical indications.

In the decision, CMS states that “[t]he evidence is inadequate to conclude that cardiac computed tomographic angiography (CTA) is reasonable and necessary under section 1862(a)(1)(A) for the diagnosis of coronary artery disease (CAD).”

January 8, 2007 - Cardiac Science Corp. expects 2007 fourth quarter revenue to total approximately $50 million, representing growth of approximately 28 percent compared with the fourth quarter of 2006, thanks to strong growth in revenue from its defibrillation products and cardiac monitoring line.

January 8, 2008 – Young, obese women with polycystic ovary syndrome (PCOS) may be at increased risk for early subclinical coronary atherosclerosis, independent of the presence of traditional cardiovascular risk factors and novel inflammatory risk markers, according to a study by researchers at the University of Iowa published in the December issue of the Journal of Clinical Endocrinology and Met

January 8, 2008 - Compared with paclitaxel-eluting stents (PES), sirolimus-eluting stents (SES) appear to decrease the risk of in-stent late luminal loss in diabetics with coronary artery disease, new research shows.

Subscribe Now